首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1563137

藥用輔料：全球市場（~2029）

Excipients in Pharmaceuticals: Global Markets to 2029

出版日期: 2024年09月27日 | 出版商:

BCC Research | 英文 105 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球藥用輔料市場規模預計到 2029年終將達到 124 億美元，預測期內複合年成長率為 5.1%，從 2023 年的 92 億美元到 2024 年的 97 億美元。

有機輔料產業預計將從 2024 年的 87 億美元成長到 2029年終的112 億美元，複合年成長率為 5.2%。無機藥用輔料產業預計將從 2024 年的 7.163 億美元成長到 2029年終的8.617 億美元，複合年成長率為 3.8%。

本報告調查了全球藥用輔料市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測、各種分類和詳細區域分析。、競爭格局以及主要企業簡介。

市場動態簡介
市場促進因素
藥品和生物藥品消費量增加
對功能性添加劑的需求增加
新添加劑的需求增加
即時採購輔料
市場限制因素
開發成本高
新添加劑缺乏獨立監管機構
嚴格的藥品法規
市場機會
對生物製藥、生物相似藥和特種藥物的需求增加
市場挑戰
供應鏈中斷

第4章新興科技與發展

概述
藥物配方中的 3D 列印
人工智慧在添加劑選擇的應用
新輔料
臨床試驗
主要臨床試驗

第5章全球藥用輔料市場

細分細分
市場區隔：依材料類型
有機添加劑：按類型
無機添加劑：依類型
USP 水：按類型
市場區隔：按劑型
市場區隔：依途徑
市場區隔：按最終用戶
地域分佈
市場區隔：按地區
北美洲
歐洲
亞太地區
拉丁美洲
其他領域
市場區隔：按產品
有機添加劑：區域和各國市場
無機添加劑：區域和各國市場

第6章競爭訊息

產業場景
企業市場占有率
競爭格局

第7章藥用輔料市場的永續性：ESG 視角

ESG：簡介
環境績效
社會表現
管治績效
BCC的結語

第8章附錄

調查方法
簡稱
參考
公司簡介
ADM
ASAHI KASEI CORP.
ASHLAND
BASF SE
CRODA INTERNATIONAL PLC
EVONIK INDUSTRIES AG
INGREDION
KERRY GROUP PLC
ROQUETTE FRERES

簡介目錄圖表

Product Code: PHM010M

The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.

The global market for organic excipients is expected to grow from $8.7 billion in 2024 to $11.2 billion by the end of 2029, at a CAGR of 5.2% from 2024 to 2029.

The global market for inorganic pharmaceutical excipients is expected to grow from $716.3 million in 2024 to $861.7 million by the end of 2029, at a CAGR of 3.8% from 2024 to 2029.

Report Scope

This report provides a comprehensive summary of pharmaceutical excipients, along with a discussion of the competitive landscape and profiles of key market players that highlight revenues, product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters will find useful information about market developments and trends. The report segments the market by three product types: organic, inorganic or water that meets the standards of the U.S. Pharmacopeia (USP). Regional and country-level market analysis is provided for all the major segments. The market excludes the excipients used in the cosmetics, food and beverage, and chemical industries.

The market is divided into segments as follows:

By excipient material type:

Organic.
Inorganic.
USP water.

By organic type:

Carbohydrates.
Petrochemicals.
Oleochemicals.
Proteins.
Other organic excipients.

By inorganic type:

Calcium salts.
Halites.
Metal oxides.
Silicates.
Other inorganic excipients.

By dosage form:

Solid dosage form.
Liquid dosage form.
Semisolid dosage form.
Other dosage forms.

By administration route:

Oral.

Injectable.
Topical.
Advanced drug delivery.

By end user:

Pharmaceutical companies.
Contract formulators.
Research institutes.
Other end users.

For each area, for the base year of 2023, BCC Research identified the current products in the market as well as market drivers; measured the current market size; quantified current company market shares; and made forecasts for 2029.

Report Includes

73 data tables and 33 additional tables
An overview of the global market for excipients in pharmaceuticals industry
Analysis of global market trends, featuring historical revenue data from 2021 to 2023, estimated figures for 2024, and projected CAGRs through 2029
Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by material, product type, dosage form, route of administration, end user and region
A look at the innovations, technological advances, clinical trials, and recent product launches
Analysis of the industry's regulatory framework and policies
A discussion of ESG challenges and ESG practices in the industry
An analysis of the key companies' market shares, proprietary technologies, strategic alliances and patents
Profiles of the leading players, including ADM, BASF SE, Roquette Freres, Ashland Global, and Croda International Plc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Role of Excipients in Pharmaceuticals
Functions of Excipients

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Increasing Pharmaceutical and Biopharmaceutical Consumption
Increasing Demand for Functional Excipients
Increasing Demand for Novel Excipients
Instant Sourcing of Excipients
Market Restraints
High Development Costs
Lack of Independent Regulatory Body for Novel Excipients
Stringent Pharmaceutical Regulations
Market Opportunities
Growing Demand for Biologics, Biosimilars and Specialty Drugs
Market Challenges
Supply Chain Disruptions

Chapter 4 Emerging Technologies and Developments

Overview
3D Printing in Drug Formulations
AI in Excipient Selection
Novel Excipients
Clinical Trials
Selected Trials

Chapter 5 Global Market for Pharmaceutical Excipients

Segmentation Breakdown
Market Breakdown by Material Type
Organic Excipients Market, by Type
Market for Inorganic Excipients, by Type
Market for USP Water, by Type
Market Breakdown by Dosage Form
Market Breakdown by Route of Administration
Market Breakdown by End User
Geographic Breakdown
Market Breakdown by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Market Breakdown by Product
Regional and Country-level Markets for Organic Excipients
Regional and Country-level Markets for Inorganic Excipients

Chapter 6 Competitive Intelligence

Industry Scenario
Company Shares
Competitive Landscape

Chapter 7 Sustainability in the Market for Pharmaceutical Excipients: An ESG Perspective

Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC

Chapter 8 Appendix

Research Methodology
Abbreviations
References
Company Profiles
ADM
ASAHI KASEI CORP.
ASHLAND
BASF SE
CRODA INTERNATIONAL PLC
EVONIK INDUSTRIES AG
INGREDION
KERRY GROUP PLC
ROQUETTE FRERES

簡介目錄圖表

List of Tables

Summary Table : Global Market for Pharmaceutical Excipients, by Material Type, Through 2029
Table 1 : Cases of Diabetes, by Country, 2021
Table 2 : People Living with HIV Globally, by Region, 2022
Table 3 : Global Incidence of All Cancers, by Region, 2022-2045
Table 4 : Clinical Trials of Pharmaceutical Excipients
Table 5 : Global Market for Pharmaceutical Excipients, by Material Type, Through 2029
Table 6 : Global Market for Organic Excipients, by Product Type, Through 2029
Table 7 : Global Market for Carbohydrate Pharmaceutical Excipients, by Type, Through 2029
Table 8 : Global Market for Sugar Pharmaceutical Excipients, by Type, Through 2029
Table 9 : Global Market for Cellulose Pharmaceutical Excipients, by Type, Through 2029
Table 10 : Global Market for Starch Pharmaceutical Excipients, Through 2029
Table 11 : Global Market for Petrochemical-based Pharmaceutical Excipients, by Type, Through 2029
Table 12 : Global Market for Mineral Hydrocarbon-based Pharmaceutical Excipients, by Type, Through 2029
Table 13 : Global Market for Oleochemical-based Pharmaceutical Excipients, by Type, Through 2029
Table 14 : Global Market for Protein-based Pharmaceutical Excipients, by Type, Through 2029
Table 15 : Global Market for Other Organic Pharmaceutical Excipients, by Type, Through 2029
Table 16 : Global Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 17 : Global Market for USP Water, Through 2029
Table 18 : Global Market for Pharmaceutical Excipients, by Dosage Form, Through 2029
Table 19 : Global Market for Pharmaceutical Excipients, by Route of Administration, Through 2029
Table 20 : Global Market for Pharmaceutical Excipients, by End User, Through 2029
Table 21 : Global Market for Pharmaceutical Excipients, by Region, Through 2029
Table 22 : North American Market for Pharmaceutical Excipients, by Country, Through 2029
Table 23 : European Market for Pharmaceutical Excipients, by Country, Through 2029
Table 24 : Asia-Pacific Market for Pharmaceutical Excipients, by Country, Through 2029
Table 25 : Latin American Market for Pharmaceutical Excipients, by Country, Through 2029
Table 26 : RoW Market for Pharmaceutical Excipients, Through 2029
Table 27 : North American Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 28 : U.S. Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 29 : Canadian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 30 : Mexican Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 31 : European Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 32 : German Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 33 : French Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 34 : U.K. Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 35 : Italian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 36 : Spanish Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 37 : Rest of European Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 38 : Asia-Pacific Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 39 : Chinese Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 40 : Japanese Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 41 : Indian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 42 : Rest of Asia-Pacific Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 43 : Latin American Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 44 : Brazilian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 45 : Argentinian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 46 : Chilean Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 47 : RoW Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 48 : North American Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 49 : U.S. Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 50 : Canadian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 51 : Mexican Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 52 : European Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 53 : German Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 54 : French Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 55 : U.K. Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 56 : Italian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 57 : Spanish Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 58 : Rest of European Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 59 : Asia-Pacific Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 60 : Chinese Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 61 : Japanese Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 62 : Indian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 63 : Rest of Asia-Pacific Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 64 : Latin American Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 65 : Brazilian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 66 : Argentinian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 67 : Chilean Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 68 : RoW Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 69 : ESG: Environmental Performance
Table 70 : ESG: Social Performance
Table 71 : ESG: Governance Performance
Table 72 : Abbreviations Used in This Report
Table 73 : ADM: Company Snapshot
Table 74 : ADM: Financial Performance, 2022 and 2023
Table 75 : ADM: Product Portfolio
Table 76 : Asahi Kasei Corp.: Company Snapshot
Table 77 : Asahi Kasei Corp.: Financial Performance, 2022 and 2023
Table 78 : Asahi Kasei Corp.: Product Portfolio
Table 79 : Ashland: Company Snapshot
Table 80 : Ashland: Financial Performance, 2022 and 2023
Table 81 : Ashland: Product Portfolio
Table 82 : Ashland.: News/Key Developments, 2022
Table 83 : BASF SE: Company Snapshot
Table 84 : BASF SE: Financial Performance, 2022 and 2023
Table 85 : BASF SE: Product Portfolio
Table 86 : BASF SE: News/Key Developments, 2023
Table 87 : Croda International Plc: Company Snapshot
Table 88 : Croda International Plc: Financial Performance, 2022 and 2023
Table 89 : Croda International Plc: Product Portfolio
Table 90 : Croda International Plc: News/Key Developments, 2023
Table 91 : Evonik Industries AG: Company Snapshot
Table 92 : Evonik Industries AG: Financial Performance, 2022 and 2023
Table 93 : Evonik Industries AG: Product Portfolio
Table 94 : Evonik.: News/Key Developments, 2023
Table 95 : Ingredion: Company Snapshot
Table 96 : Ingredion: Financial Performance, FY 2022 and 2023
Table 97 : Ingredion: Product Portfolio
Table 98 : Ingredion: News/Key Developments, 2023
Table 99 : Kerry Group Plc: Company Snapshot
Table 100 : Kerry Group Plc: Financial Performance, 2022 and 2023
Table 101 : Kerry Group Plc: Product Portfolio
Table 102 : Kerry Group Plc: News/Key Developments, 2023
Table 103 : Roquette Freres: Company Snapshot
Table 104 : Roquette Freres: Product Portfolio
Table 105 : Roquette Freres: News/Key Developments, 2023 and 2024

List of Figures

Summary Figure A : Global Market for Pharmaceutical Excipients, by Material Type, 2021-2029
Summary Figure B : Global Market Shares of Pharmaceutical Excipients, by Material Type, 2023
Figure 1 : Pharmaceutical Excipients: Market Dynamics
Figure 2 : Emerging Trends and Technologies in Pharmaceutical Excipients
Figure 3 : Global Market Shares of Pharmaceutical Excipients, by Company, 2023
Figure 4 : ESG Pillars
Figure 5 : Advantages of ESG for Pharmaceutical Excipient Companies
Figure 6 : ADM: Revenue Share, by Business Unit, 2023
Figure 7 : Asahi Kasei Corp.: Revenue Share, by Business Unit, 2023
Figure 8 : Asahi Kasei Corp.: Revenue Share, by Country/Region, 2023
Figure 9 : Ashland: Revenue Share, by Business Unit, 2023
Figure 10 : Ashland: Revenue Share, by Region, 2023
Figure 11 : BASF SE: Revenue Share, by Business Unit, 2023
Figure 12 : BASF SE: Revenue Share, by Region, 2023
Figure 13 : Croda International Plc: Revenue Share, by Business Unit, 2023
Figure 14 : Croda International Plc: Revenue Share, by Region, 2023
Figure 15 : Evonik Industries AG: Revenue Share, by Business Unit, 2023
Figure 16 : Evonik Industries AG: Revenue Share, by Region, 2023
Figure 17 : Ingredion: Revenue Shares, by Business Unit, 2023
Figure 18 : Ingredion: Revenue Share, by Region, 2023
Figure 19 : Kerry Group Plc: Revenue Share, by Business Unit, 2023
Figure 20 : Kerry Group Plc: Revenue Share, by Region, 2023